The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 Human Genome Sciences Inc  (HGSI) Trade Now »     Rate HGSI  -  Discuss HGSI  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
SocialPicks Sentiment:

** v.s. other stocks 		This Quarter's Sentiment:
All:
75.0%
Top:
0.0%
Rate HGSI:


Home
Analysis & Videos
Quotes
Bull or Bear
Discuss
        

HGSI: Bull or Bear? From:    SocialPicks  |  Blogsphere  |  All

SocialPicks Community

Bullish on HGSI ... Graphic_rating_buy HGSI
Foto
62%
Human Genome Sciences, Inc. operates as a biopharmaceutical company in the United States. The companyÂ’s clinical development pipeline includes novel drugs to treat hepatitis C, lupus, inhalation anthrax, and cancer. It focuses on the commercialization of Albuferon (albinterferon alfa-2b) for hepatitis C and LymphoStat-B (belimumab) for lupus. The company has completed Phase III development trials for Albuferon and is conducting two Phase III clinical trials of LymphoStat-B. It also delivers doses of ABthrax (raxibacumab) to the U.S. Strategic National Stockpile for use in the event of an e...
By  Marian Filo   (-24.55%  risk: aggressive)  04/17/09 Comment


Updated Clinical Trial and FDA Decision Calendars Graphic_rating_sell HGSI
Mikerun
73%
<> <> Below is a summary of updates to the www.BioMedReports.com database of 242 entries included in the FDA and Clinical Trial Calendars. The two web links below are for the FDA calendar home page and a recent article highlighting 14 extreme trades of companies with market caps below $200M with pending FDA decisions.

http://biomedreports <wbr> </wbr> .com/fda-calendar.ht <wbr> </wbr> ml

http://biomedreports <wbr> </wbr> .com/articles/most-p <wbr> </wbr> opular/627-trading-f <wbr> </wbr> da-decisions-14-extr <wbr> </wbr> eme-trades.html

The FDA Calenda...
By  Mike Havrilla   (+1.04%  risk: conservative)  03/15/09 Comment


Emerging Biotech & Pharma Index: 36 More Companies Graphic_rating_sell HGSI
Mikerun
73%

Emerging Biotech & Pharma Index: 36 More Cos.

<>
The accompanying table [click to enlarge or download] includes the 36 remaining companies in the ETF Innovators [ETFI] Emerging Bio-Pharma Index with market caps between $150M-$1.5B, which were not included in the previous two articles I wrote about the group – featuring the Top 40 Rated Companies and companies below the $150M market cap cutoff.

However, several of the companies included in the remaining group of 36 have been in the news recently due to FDA related news . Late last week, Ligand Phar...
By  Mike Havrilla   (+1.04%  risk: conservative)  11/23/08 Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.44% 381
2 Gerald Greene 18.14 +71.24% 211
3 stockmarketfunding.com 17.66 +25.60% 55
4 akiralegrand 13.47 +14.32% 62
5 anup2104 12.13 +74.22% 40


POPULAR STOCKS
Symbol Company Name Sentiment
GLD streetTRACKS Gold
PG The Procter & Gamble Company
WM Washington Mutual Inc
RIMM Research in Motion Ltd
WFC Wells Fargo & Company
JNJ Johnson & Johnson

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on HGSI

Visit streetinsider.com


Discussion Wall + Add  
amritadas   (+0.00%)
Free report on upcoming FDA panel decision of Corvu.. - FDA Panel to review this Biotech company's stress agent drug on July 28th. If they get a favorable backing by the panel, the chances of approval by th...
+   0 replies


More Resources

Graphic_arrow1 About Human Genome Sciences Inc - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch